Adalimumab

Details

Files

Generic Name:

Adalimumab

Project Status:

Complete

Therapeutic Area:

Arthritis, juvenile idiopathic

Manufacturer:

AbbVie Corporation

Call for patient/clinician input open:

January 4, 2013

Brand Name:

Humira

Project Line:

Reimbursement Review

Project Number:

SR0308-000

Call for patient/clinician input closed:

February 22, 2013

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, Juvenile Idiopathic

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

July 18, 2013

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : February 4, 2013